Last update 23 Mar 2025

Albumin-erythropoietin fusion protein(Tianjin Puying Biotechnology Co Ltd)

Overview

Basic Info

Drug Type
Colony-stimulating factors
Synonyms-
Target
EPO receptor
Action
agonists, stimulants
Mechanism
EPO receptor agonists(Erythropoietin receptor agonists), Erythropoiesis stimulants(Erythropoiesis stimulants)
Therapeutic Areas
Hemic and Lymphatic Diseases
Active Indication
Anemia of renal disease
Inactive Indication-
Originator Organization
Tianjin PuYing Biotechnology Co., Ltd.Tianjin PuYing Biotechnology Co., Ltd.
Active Organization
Fortunerock (China) Co. Ltd.Fortunerock (China) Co. Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Albumin-erythropoietin fusion protein(Tianjin Puying Biotechnology Co Ltd)
CTR20181592
/ Not yet recruitingPhase 1
注射用重组人血清白蛋白/促红素融合蛋白单次给药、剂量递增的耐受性、安全性、药代动力学和药效学临床试验
[Translation] Clinical trial on the tolerability, safety, pharmacokinetics and pharmacodynamics of single-dose and dose-escalation recombinant human serum albumin/erythropoietin fusion protein for injection
100 Clinical Results associated with Albumin-erythropoietin fusion protein(Tianjin Puying Biotechnology Co Ltd)
Login to view more data
100 Translational Medicine associated with Albumin-erythropoietin fusion protein(Tianjin Puying Biotechnology Co Ltd)
Login to view more data
100 Patents (Medical) associated with Albumin-erythropoietin fusion protein(Tianjin Puying Biotechnology Co Ltd)
Login to view more data
100 Deals associated with Albumin-erythropoietin fusion protein(Tianjin Puying Biotechnology Co Ltd)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Anemia of renal diseasePhase 1
China
Fortunerock (China) Co. Ltd.Fortunerock (China) Co. Ltd.
05 Dec 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Biosimilar

Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
view full example data
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free